A simple dataset for demonstrating basic swimmer plot functionality. Contains patient timelines with treatment responses and basic categorization.
Usage
data(swimmer_unified_basic)
Format
A data frame with 10 rows and 6 variables:
- PatientID
Character. Unique patient identifiers (PT001-PT010)
- StartTime
Numeric. Treatment start time (all patients start at 0)
- EndTime
Numeric. Treatment end time in months (5-15 months)
- Response
Character. Best response (CR, PR, SD, PD)
- Treatment
Character. Treatment type (Immunotherapy, Chemotherapy, Combination, Targeted)
- Priority
Character. Patient priority level (High, Medium, Low)
See also
Other swimmer plot datasets:
swimmer_unified_comprehensive
,
swimmer_unified_datetime
,
swimmer_unified_events
,
swimmer_unified_oncology
Examples
data(swimmer_unified_basic)
# Basic swimmer plot
swimmerplot(
data = swimmer_unified_basic,
patientID = "PatientID",
startTime = "StartTime",
endTime = "EndTime",
responseVar = "Response"
)
#>
#> SWIMMER PLOT
#>
#> character(0)
#>
#> Timeline Summary Statistics
#> ───────────────────────────────────
#> Metric Value
#> ───────────────────────────────────
#> Number of Patients 10.000000
#> Total Observations 10.000000
#> Median Duration 9.500000
#> Mean Duration 9.700000
#> Total Person-Time 97.000000
#> Mean Follow-up 9.700000
#> CR Rate (%) 30.000000
#> PD Rate (%) 20.000000
#> PR Rate (%) 30.000000
#> SD Rate (%) 20.000000
#> ───────────────────────────────────
#>
#>
#> <div style='background-color: #e8f5e8; padding: 15px; border-radius:
#> 5px; margin: 10px 0;'>
#>
#> Clinical Interpretation
#>
#> <div style='margin: 10px 0;'><h5 style='color: #2e7d32;'>Timeline
#> Analysis:
#>
#> Study included 10 patients with 10 timeline observations. Median
#> follow-up was 9.5 months (range: 5.0 to 15.0 months).
#>
#> <div style='margin: 10px 0;'><h5 style='color: #2e7d32;'>Person-Time
#> Analysis:
#>
#> Total person-time: 97.0 months. Average follow-up per patient: 9.7
#> months.
#>
#> <div style='margin: 10px 0;'><h5 style='color: #2e7d32;'>Response
#> Pattern Analysis:
#>
#> Most common response was CR (30.0% of observations). Response
#> distribution shows clinical patterns suitable for efficacy analysis.
#>
#> Person-Time Analysis
#> ──────────────────────────────────────────────────────────────────────────
#> Response Type Patients Total Time Mean Time Incidence Rate
#> ──────────────────────────────────────────────────────────────────────────
#> ──────────────────────────────────────────────────────────────────────────
#>
#>
#> Milestone Event Summary
#> ────────────────────────────────────────────────────
#> Milestone Events Median Time Time Range
#> ────────────────────────────────────────────────────
#> ────────────────────────────────────────────────────
#>
#>
#> Advanced Clinical Metrics
#> ──────────────────────────────────────────────────────
#> Metric Value Unit Clinical Interpretation
#> ──────────────────────────────────────────────────────
#> ──────────────────────────────────────────────────────
#>